'Magic pill' for weight loss now available in Australia: What you need to know about the side effects, how it works and how much it costs

Resumen detallado
A tablet version of 'miracle' weight loss drug Wegovy has hit the shelves in Australian pharmacies - but experts have warned it comes with some unpleasant side effects.
Published: 01:03 GMT, 20 November 2026 | Updated: 01:03 GMT, 20 November 2026
A tablet version of weight loss drug Wegovy has hit the shelves in Australian pharmacies, becoming the first weight-loss tablet to be sold domestically. However, experts have warned it comes with some unpleasant side effects.
The medication, dubbed the 'magic pill', administers semaglutide into the body, which acts on the brain and digestive system to help decrease appetite, increase feelings of fullness and slow the digestion of food. However, experts warned that 'common side effects - affecting around 80 per cent of patients - include nausea, vomiting, diarrhoea, indigestion and constipation'.
'Less common, but more serious side effects include kidney injury, pancreatitis and gallbladder problems,' said Kimberley Akrigg, a PhD candidate at the School of Public Health, The University of Queensland.
'Doctor appointments are short, meaning they sometimes lack proper screening for eating disorders, body image or other psychological issues.
'Previous research has also highlighted a link between suicidal thoughts and use. So, unless these issues are discussed in appointments, it could lead to negative outcomes for patients.
'Higher doses make negative side effects more severe. With a tablet, it's important for people to know that, just as for an injection, doubling up their dose won't encourage faster results and could cause harm.'
Despite the side effects, trials of the drug have proven remarkably effective, with tablet users showing 14 per cent body weight loss over 64 to 68 weeks.
The pill should be taken 'daily, on an empty stomach, with a small amount of water', followed by a 30-minute wait before eating anything.
Inicio del artículo, extracto de Daily Mail. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.dailymail.com)





